Novo Nordisk A/S
34 products tracked · names used in filings: Novo Nordisk A/S, Novo Nordisk Inc
Upcoming milestones
Frehemgo (denecimig): expected EC decision
Estimated as CHMP opinion (2026-09-17) + 67 days, the standard Commission decision period. Not an official date. · Novo Nordisk A/S · source
Recent milestones
Frehemgo (denecimig): CHMP positive opinion
FDA approves Awiqli Flextouch (insulin icodec), a new medicine
Novo Nordisk Inc; BLA761326; New biologic; injection · source
Kayshild (semaglutide) approved in the EU
Marketing authorisation to Novo Nordisk A/S; Conditional, Additional monitoring · source
Kayshild (semaglutide): CHMP positive opinion
Novo Nordisk A/S; Conditional, Additional monitoring · source
Kyinsu (insulin icodec;semaglutide) approved in the EU
Marketing authorisation to Novo Nordisk A/S; Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Frehemgo denecimig | Opinion | |
| 🇺🇸 | Awiqli Flextouch insulin icodec | Approved | 2026-03-26 |
| 🇪🇺 | Kayshild semaglutide | Authorised | 2026-03-26 |
| 🇪🇺 | Kyinsu insulin icodec;semaglutide | Authorised | 2025-11-24 |
| 🇪🇺 | Alhemo concizumab | Authorised | 2024-12-13 |
| 🇪🇺 | Awiqli insulin icodec | Authorised | 2024-05-17 |
| 🇪🇺 | Wegovy semaglutide | Authorised | 2022-01-06 |
| 🇪🇺 | Sogroya somapacitan | Authorised | 2021-03-31 |
| 🇪🇺 | Rybelsus semaglutide | Authorised | 2020-04-03 |
| 🇪🇺 | Esperoct turoctocog alfa pegol | Authorised | 2019-06-20 |
| 🇪🇺 | Ozempic semaglutide | Authorised | 2018-02-08 |
| 🇪🇺 | Refixia nonacog beta pegol | Authorised | 2017-06-02 |
| 🇪🇺 | Fiasp insulin aspart | Authorised | 2017-01-09 |
| 🇪🇺 | Saxenda liraglutide | Authorised | 2015-03-23 |
| 🇪🇺 | Xultophy insulin degludec;liraglutide | Authorised | 2014-09-18 |
| 🇪🇺 | NovoEight turoctocog alfa | Authorised | 2013-11-13 |
| 🇪🇺 | Ryzodeg insulin degludec;insulin aspart | Authorised | 2013-01-21 |
| 🇪🇺 | Tresiba insulin degludec | Authorised | 2013-01-20 |
| 🇪🇺 | NovoThirteen catridecacog | Authorised | 2012-09-03 |
| 🇪🇺 | Victoza liraglutide | Authorised | 2009-06-30 |
| 🇪🇺 | Levemir insulin detemir | Authorised | 2004-06-01 |
| 🇪🇺 | Mixtard insulin human (rDNA) | Authorised | 2002-10-07 |
| 🇪🇺 | Actraphane insulin human (rDNA) | Authorised | 2002-10-07 |
| 🇪🇺 | Ultratard insulin human (rDNA) | Withdrawn | 2002-10-07 |
| 🇪🇺 | Insulatard insulin human (rDNA) | Authorised | 2002-10-07 |
| 🇪🇺 | Protaphane insulin human (rDNA) | Authorised | 2002-10-07 |
| 🇪🇺 | Actrapid human insulin (rDNA) | Authorised | 2002-10-07 |
| 🇪🇺 | Velosulin insulin human (rDNA) | Withdrawn | 2002-10-07 |
| 🇪🇺 | Monotard insulin human (rDNA) | Withdrawn | 2002-10-07 |
| 🇪🇺 | Prandin repaglinide | Authorised | 2001-01-29 |
| 🇪🇺 | NovoMix insulin aspart | Authorised | 2000-08-01 |
| 🇪🇺 | NovoRapid insulin aspart | Authorised | 1999-09-07 |
| 🇪🇺 | NovoNorm repaglinide | Authorised | 1998-08-16 |
| 🇪🇺 | NovoSeven eptacog alfa (activated) | Authorised | 1996-02-23 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.